|
KIAA1267 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.24285043262762E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.15139947260468E-10 |
| Normal-vs-Stage2 |
6.06380000000017E-05 |
| Normal-vs-Stage3 |
7.64699414901315E-12 |
| Normal-vs-Stage4 |
1.84460002827791E-10 |
| Stage1-vs-Stage2 |
5.545200E-01 |
| Stage1-vs-Stage3 |
7.132100E-02 |
| Stage1-vs-Stage4 |
2.883700E-02 |
| Stage2-vs-Stage3 |
7.177900E-02 |
| Stage2-vs-Stage4 |
4.640000E-02 |
| Stage3-vs-Stage4 |
6.166400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.34743344154731E-12 |
| Normal-vs-AfricanAmerican |
6.174000E-04 |
| Normal-vs-Asian |
1.02909999966094E-07 |
| Caucasian-vs-AfricanAmerican |
4.095400E-01 |
| Caucasian-vs-Asian |
7.621800E-01 |
| AfricanAmerican-vs-Asian |
5.355600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.237599491423E-10 |
| Normal-vs-Female |
9.46154266046051E-12 |
| Male-vs-Female |
9.197200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.68280001044963E-09 |
| Normal-vs-Age(41-60Yrs) |
8.7337004295307E-10 |
| Normal-vs-Age(61-80Yrs) |
1.69059988230913E-10 |
| Normal-vs-Age(81-100Yrs) |
1.702810E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.016600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.269000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.755000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.489400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.440800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.370200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
8.023400E-04 |
| Classical-VS-Follicular |
9.665600E-01 |
| Classical-VS-Other |
9.975400E-01 |
| Classical-VS-Normal |
5.23330268009659E-11 |
| Tall-VS-Follicular |
6.182200E-03 |
| Tall-VS-Other |
3.502600E-01 |
| Tall-VS-Normal |
3.66490171543887E-11 |
| Follicular-VS-Other |
9.916800E-01 |
| Follicular-VS-Normal |
1.85529999996437E-06 |
| Other-VS-Normal |
2.881600E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.94770002745781E-09 |
| Normal-vs-N1 |
3.11810022246561E-10 |
| N0-vs-N1 |
7.130200E-02 |
|
|
